Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug Development-Reference-Cited by-同舟云学术

Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug Development

Published:2023-06-02 Issue:4 Volume:25 Page:
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Gokemeijer Jochem,Wen Yi,Jawa Vibha,Mitra-Kaushik Shibani,Chung Shan,Goggins Alan,Kumar Seema,Lamberth Kasper,Liao Karen,Lill Jennie,Phung Qui,Walsh Robin,Roberts Brian J.,Swanson Michael,Singh Inderpal,Tourdot Sophie,Kroenke Mark A.,Rup Bonita,Goletz Theresa J.,Gupta Swati,Malherbe Laurent,Pattijn Sofie

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1208/s12248-023-00820-7.pdf

Reference40 articles.

1. Walsh RE, Lannan M, Wen Y, Wang X, Moreland CA, Willency J, et al. Post-hoc assessment of the immunogenicity of three antibodies reveals distinct immune stimulatory mechanisms. mAbs. 2020;12(1):1764829.

2. Jenkins MK, Moon JJ. The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J Immunol. 2012;188(9):4135–40.

3. Delluc S, Ravot G, Maillere B. Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors. FASEB J. 2011;25(6):2040–8.

4. Hamze M, Meunier S, Karle A, Gdoura A, Goudet A, Szely N, et al. Characterization of CD4 T cell epitopes of infliximab and rituximab identified from healthy donors. Front Immunol. 2017;8:500.

5. Ducret A, Ackaert C, Bessa J, Bunce C, Hickling T, Jawa V, et al. Assay format diversity in pre-clinical immunogenicity risk assessment: toward a possible harmonization of antigenicity assays. MAbs. 2022;14(1):1993522.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of Quality by Design (QbD) Principles in the Engineering of an Oral Delivery Nanosystem Loaded with Fenofibrate;International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN);2024-08-15

2. Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG ₁ antibodies;mAbs;2024-06-06

3. Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays;Frontiers in Immunology;2024-05-28

4. T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics;mAbs;2024-03-21

5. Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies;BioDrugs;2024-01-23